OMER Omeros Corporation
Healthcare$11.65+1.66%ClosedMarket Cap: $843.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-13.01
P/S
83.84
EV/EBITDA
-10.91
DCF Value
$-3.18
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-12.4%
Operating Margin
-1063.9%
Net Margin
871.0%
ROE
-54.4%
ROA
30.1%
ROIC
-40.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $9.9M | 91.7% | $-17.4M | $56.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-29.1M | $86.5M | $— | — |
| FY null | $0.00 | NaN% | $-122.8M | $-3.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-26.4M | $-30.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-32.4M | $-25.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-35.0M | $-33.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-35.7M | $-31.4M | $— | — |
| FY null | $0.00 | NaN% | $-169.3M | $-156.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-35.4M | $-32.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-59.2M | $-56.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-39.0M | $-37.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-39.8M | $-9.1M | $-0.15 | — |